Real Estate
Filter News
Found 7,338 articles
-
PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Cincinnati
4/22/2024
PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.
-
The new Cambridge, Mass.–based facility is about 460,000 square feet. Labs occupy nearly 50% of the space.
-
Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide
4/3/2024
The leading pharmaceutical company in the Baltics, Grindeks, is developing new products and reinforcing its position not only in European but also global markets.
-
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
3/21/2024
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced that one of its subsidiaries, AiBtl BioPharma Inc., entered into an Agreement to exchange a 100% ownership stake in certain real estate for 1,533,333 shares of AIBL stock at $5 per share.
-
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
3/18/2024
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive awards and will expand SCHOTT Group’s presence in the United States, a strategic market in its growth plan.
-
Recursion Announces Plans to Open New Office in London
3/11/2024
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
-
Amgen Opens State-of-the-Art Biomanufacturing Site in Central Ohio
2/26/2024
Amgen announced the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.
-
Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office
2/15/2024
Sosei Group Corporation, announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of the Company and its subsidiaries and the location of the head office of the Company.
-
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
2/8/2024
ABVC BioPharma, Inc. announced that it signed a definitive agreement to acquire real estate in Taoyuan City, Taiwan.
-
AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development
2/6/2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply.
-
Empower Pharma to Purchase Eugia Manufacturing Facility in New Jersey for Large Scale Expansion of Personalized Compounded Medicine
2/5/2024
Empower Clinic Services New Jersey LLC DBA Empower Pharma announced an agreement to purchase a facility in East Windsor, New Jersey from Eugia US Manufacturing LLC and enter into a contract manufacturing relationship.
-
Kraton Completes $35M Investment in Biorefinery Towers at Panama City Facility
1/29/2024
Kraton Corporation has completed a $35 million investment to upgrade its crude tall oil biorefinery towers in its Panama City, Florida manufacturing facility.
-
Alcami Opens New Advanced Pharma Storage and Services Facility in Central North Carolina
1/24/2024
Alcami Corporation announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.
-
Eurofins Genomics Opens New Seattle Laboratory for Express Oxford Nanopore Sequencing
1/24/2024
Eurofins Genomics, a global leader in sequencing services, announces the opening of a new, certified sequencing lab in Bothell, Washington, serving the greater Seattle area.
-
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
1/23/2024
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the operational readiness of its new proteomics facility in Massachusetts.
-
Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance
1/17/2024
Chiron AS, a leading producer of chemical reference materials headquartered in Trondheim, Norway, is pleased to announce the establishment of a state-of-the-art research centre dedicated to the enhanced surveillance of environmental pollutants.
-
Chemical Insights Research Institute Commits to Public Health Research with the Opening of New Laboratories
1/11/2024
Chemical Insights Research Institute of UL Research Institutes confirmed its commitment to protecting environmental and human health when it opened its new research laboratories supporting scientific studies of environmental exposure and its societal health impact.
-
Boehringer expands production site in Greece for new medicine
1/11/2024
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced a further expansion and upgrade of its plant in Koropi, Greece.
-
QIAGEN expands business in Middle East with new regional headquarters and major projects
1/3/2024
QIAGEN announced a significant expansion of its business in the Middle East region, which includes three major developments.
-
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
1/2/2024
Psychemedics Corporation proudly announces the relocation of its corporate headquarters from Acton, Massachusetts, to Dallas, Texas, while reaffirming its unwavering dedication to delivering exceptional service and maintaining the highest standards in hair drug testing.